
The BluePearl Greater Philadelphia network hospitals are offering a funded study evaluating the first-in-class liquid biopsy test from PetDx in 2022.
The BluePearl Greater Philadelphia network hospitals are offering a funded study evaluating the first-in-class liquid biopsy test from PetDx in 2022.
A novel immunotherapy for dogs with osteosarcoma is discussed.
Published: September 16th 2021 | Updated:
Published: January 30th 2022 | Updated: